scispace - formally typeset
R

Robert B. McLafferty

Researcher at Oregon Health & Science University

Publications -  90
Citations -  5950

Robert B. McLafferty is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Chronic venous insufficiency & Venous thrombosis. The author has an hindex of 34, co-authored 90 publications receiving 5232 citations. Previous affiliations of Robert B. McLafferty include United States Department of Veterans Affairs & Southern Illinois University School of Medicine.

Papers
More filters
Journal ArticleDOI

Mechanism of failure in the treatment of type II endoleak with percutaneous coil embolization.

TL;DR: PTCE of type II endoleaks has a high failure rate because of multiple anatomic mechanisms and mechanisms of failure included persistent flow through the coils in the treated vessel in two patients, development of a retiform anastomosis around the coiled vessel in three patients, andDevelopment of a new mesenteric endoleak after successful occlusion of an iliolumbar endoleAK in one patient.
Journal ArticleDOI

Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients.

TL;DR: The effects of a new long-term subcutaneous vascular access device were studied in access-challenged patients who were poor candidates for fistulas or grafts due to venous obstruction and found the device had similar function and patency compared with conventional arteriovenous graft literature.
Journal ArticleDOI

Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia

TL;DR: Examination of wound healing and the functional natural history of patients undergoing infrainguinal bypass with reversed saphenous vein for critical limb ischemia (CLI) indicated that extensive pedal necrosis at presentation independently predicted delayed wound healing.
Journal ArticleDOI

Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: Implications for clinical trial design

TL;DR: More than half of critical limb ischemia patients undergoing infrainguinal revascularization have arterial occlusions in the popliteal or tibial arterial segments, or both, with associated critical stenoses in the femoral arterIAL segments, which is even greater in the subgroups with diabetes mellitus, end-stage renal disease, and Fontaine stage IV.